tiprankstipranks
Advertisement
Advertisement

IN:DRREDDY Stock Latest News

Dr. Reddy’s Russian arm hit with reduced VAT penalty, seen as immaterial
Company AnnouncementsDr. Reddy’s Russian arm hit with reduced VAT penalty, seen as immaterial
9h ago
Dr. Reddy’s launches India’s first DCGI‑approved generic semaglutide injection Obeda
PremiumCompany Announcements
Dr. Reddy’s launches India’s first DCGI‑approved generic semaglutide injection Obeda
25d ago
Dr. Reddy’s clarifies Delhi High Court ruling on semaglutide exports
PremiumCompany Announcements
Dr. Reddy’s clarifies Delhi High Court ruling on semaglutide exports
1M ago
Dr. Reddy’s Srikakulam Plant Clears USFDA Inspection With VAI Classification
PremiumCompany Announcements
Dr. Reddy’s Srikakulam Plant Clears USFDA Inspection With VAI Classification
1M ago
Dr. Reddy’s reports FDA acceptance to review Abatacept BLA
PremiumThe Fly
Dr. Reddy’s reports FDA acceptance to review Abatacept BLA
2M ago
RDY
Coya Therapeutics to sell 2.522M shares at $4.40 in private placement
PremiumThe FlyCoya Therapeutics to sell 2.522M shares at $4.40 in private placement
2M ago
RDY
COYA
Dr. Reddy’s Posts Q3 FY26 Earnings Call Transcript for Investors
Premium
Company Announcements
Dr. Reddy’s Posts Q3 FY26 Earnings Call Transcript for Investors
3M ago
Dr. Reddy’s Publishes Audio Recording of Q3 FY2026 Earnings Call
Premium
Company Announcements
Dr. Reddy’s Publishes Audio Recording of Q3 FY2026 Earnings Call
3M ago
Dr. Reddy’s Releases Q3 FY26 Unaudited Results Investor Presentation
PremiumCompany Announcements
Dr. Reddy’s Releases Q3 FY26 Unaudited Results Investor Presentation
3M ago
Dr. Reddy’s Gets USFDA Post-Application Action Letter for Hyderabad Biologics Plant
PremiumCompany Announcements
Dr. Reddy’s Gets USFDA Post-Application Action Letter for Hyderabad Biologics Plant
3M ago
Dr. Reddy’s Laboratories Receives USFDA Observations Post-Inspection
PremiumCompany Announcements
Dr. Reddy’s Laboratories Receives USFDA Observations Post-Inspection
4M ago
Dr. Reddy’s Laboratories to Engage with Investors at Hyderabad Conference
PremiumCompany Announcements
Dr. Reddy’s Laboratories to Engage with Investors at Hyderabad Conference
4M ago
Midday Fly By: IBM to buy Confluent, Paramount goes hostile for Warner Bros.
PremiumThe FlyMidday Fly By: IBM to buy Confluent, Paramount goes hostile for Warner Bros.
4M ago
V
GM
Immutep, Dr Reddy’s enters strategic collaboration for Eftilagimod Alfa
Premium
The Fly
Immutep, Dr Reddy’s enters strategic collaboration for Eftilagimod Alfa
4M ago
RDY
IMMP
Dr. Reddy’s Laboratories Releases Q2 FY26 Earnings Call Transcript
Premium
Company Announcements
Dr. Reddy’s Laboratories Releases Q2 FY26 Earnings Call Transcript
6M ago
Dr. Reddy’s Laboratories Receives Positive FDA Inspection Outcome
PremiumCompany Announcements
Dr. Reddy’s Laboratories Receives Positive FDA Inspection Outcome
6M ago
No jobs report amid shutdown, Apple pulls ICEBlock from App Store: Morning Buzz
PremiumThe Fly
No jobs report amid shutdown, Apple pulls ICEBlock from App Store: Morning Buzz
6M ago
Z
BA
Esperion reaches settlement agreement with ANDA filer, Dr. Reddy’s
PremiumThe Fly
Esperion reaches settlement agreement with ANDA filer, Dr. Reddy’s
6M ago
RDY
ESPR
Dr. Reddy’s Laboratories Ensures Compliance with SEBI Regulations
PremiumCompany Announcements
Dr. Reddy’s Laboratories Ensures Compliance with SEBI Regulations
7M ago
Alvotech says CHMP adopts positive opinion for AVT03
PremiumThe FlyAlvotech says CHMP adopts positive opinion for AVT03
7M ago
RDY
ALVO
Dr. Reddy’s, Extrovis launch authorized generic of CARAC in the U.S.
Premium
The Fly
Dr. Reddy’s, Extrovis launch authorized generic of CARAC in the U.S.
8M ago
RDY
Dr. Reddy’s Laboratories Releases Q1 FY26 Earnings Call Transcript
Premium
Company Announcements
Dr. Reddy’s Laboratories Releases Q1 FY26 Earnings Call Transcript
9M ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >